No clinical oversight, dosing guidance, titration support, or patient safety monitoring is provided
Examples that may be considered in certain plans: NAD+ support strategies when cellular energy regulation is part of the picture Thymosin-class peptides (such as Thymosin Alpha-1 or Thymosin Beta-4) in immune modulation discussions (case-dependent) GHK-Cu when skin and connective tissue signaling is a parallel priority Sleep-focused lifestyle and nutrient review because peptides do not compensate for chronic sleep disruption drivers More compounds is not automatically better
As always, it is wise to consult your healthcare provider to ensure it fits your specific health profile
doi: 10.1080/21641846.2022.2124775 Summary Keywords myalgic encephalomyelitis/chronic fatigue syndrome, pathology, treatment, pathophysiology, diagnostic criteria Citation Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR and Pretorius E (2024) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease